sargramostim
Showing 26 - 50 of 170
HIV Trial in San Diego, Aurora, Indianapolis (Indinavir sulfate, Lamivudine/Zidovudine, Hepatitis A Vaccine (Inactivated))
Completed
- HIV Infections
- Indinavir sulfate
- +6 more
-
San Diego, California
- +2 more
Oct 27, 2021
HIV Trial in United States (APL 400-047, ALVAC-HIV MN120TMG (vCP205), Sargramostim)
Completed
- HIV Infections
- APL 400-047
- +2 more
-
Birmingham, Alabama
- +3 more
Oct 28, 2021
Ganglioneuroblastoma, Nodular, Neuroblastoma Trial in Worldwide (Dinutuximab, Irinotecan, Isotretinoin)
Active, not recruiting
- Ganglioneuroblastoma, Nodular
- Neuroblastoma
- Dinutuximab
- +4 more
-
Mesa, Arizona
- +77 more
Aug 17, 2022
Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer Trial in Detroit (biological,
Completed
- Metastatic Pancreatic Adenocarcinoma
- +3 more
- Aldesleukin
- +9 more
-
Detroit, MichiganWayne State University/Karmanos Cancer Institute
Mar 30, 2022
Hodgkin's Lymphoma, Lymphoid Leukemia, Lymphoma Trial in Richmond (mycophenolate mofetil, Sargramostim, Filgrastim)
Active, not recruiting
- Hodgkin's Lymphoma
- +17 more
- mycophenolate mofetil
- +2 more
-
Richmond, VirginiaVirginia Commonwealth University/Massey Cancer Center
Dec 21, 2021
High Risk Neuroblastoma Trial in United States (biological, other, drug)
Completed
- High Risk Neuroblastoma
- Aldesleukin
- +4 more
-
Loma Linda, California
- +31 more
Jul 30, 2021
Lymphoma, Non-Hodgkin, HIV Trial in United States (Bleomycin sulfate, Vincristine sulfate, Doxorubicin HCl)
Completed
- Lymphoma, Non-Hodgkin
- HIV Infections
- Bleomycin sulfate
- +9 more
-
Los Angeles, California
- +21 more
Oct 26, 2021
Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Recurrent Neuroblastoma Trial in Worldwide
Active, not recruiting
- Localized Resectable Neuroblastoma
- +5 more
- Aldesleukin
- +6 more
-
Birmingham, Alabama
- +196 more
Dec 30, 2022
Squamous Cell Carcinoma of the Oral Cavity Trial in Worldwide (GL-0817, Hiltonol, Sargramostim)
Completed
- Squamous Cell Carcinoma of the Oral Cavity
- GL-0817
- +4 more
-
Baltimore, Maryland
- +32 more
Mar 4, 2022
HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer Trial in Seattle (HER-2/neu peptide vaccine,
Completed
- HER2-positive Breast Cancer
- +7 more
- HER-2/neu peptide vaccine
- +2 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Feb 4, 2020
Melanoma (Skin) Trial in Charlottesville (biological, drug, procedure)
Completed
- Melanoma (Skin)
- incomplete Freund's adjuvant
- +6 more
-
Charlottesville, VirginiaUniversity of Virginia Cancer Center
Mar 26, 2020
Prostatic Tumors Trial run by the NCI (PROSTVAC-V/TRICOM, PROSTVAC-F/TRICOM, MDX-010)
Completed
- Prostatic Neoplasms
- PROSTVAC-V/TRICOM
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 13, 2019
HIV Trial in United States (Indinavir sulfate, Sargramostim)
Completed
- HIV Infections
- Indinavir sulfate
- Sargramostim
-
Birmingham, Alabama
- +38 more
Oct 27, 2021
High Risk Neuroblastoma, Recurrent Neuroblastoma, Refractory Neuroblastoma Trial in Worldwide (Dinutuximab, Eflornithine
Recruiting
- High Risk Neuroblastoma
- +2 more
- Dinutuximab
- +4 more
-
Birmingham, Alabama
- +141 more
Dec 28, 2022
Gastric Cancer, Breast Cancer Trial in Munic (Cyclophosphamide, Sargramostim, HER2-Peptid-Vakzine)
Completed
- Gastric Cancer
- Breast Cancer
- Cyclophosphamide
- +3 more
-
Munic, Bavaria, GermanyIII.Medizinische Klinik und Poliklinik, Klinikum rechts der Isar
Nov 18, 2019
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Buffalo (biological, drug, procedure)
Completed
- Chronic Myeloproliferative Disorders
- +7 more
- anti-thymocyte globulin
- +11 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jan 29, 2020
Leukemia Trial in Baltimore (biological, drug, procedure)
Completed
- Leukemia
- filgrastim
- +10 more
-
Baltimore, MarylandGreenebaum Cancer Center at University of Maryland Medical Cente
Oct 31, 2019
Kidney Diseases, Kidney Transplant Trial in Gainesville (Sargramostim, Blood samples)
Terminated
- Kidney Diseases
- Kidney Transplant
- Sargramostim
- Blood samples
-
Gainesville, FloridaUniversity of Florida
Dec 27, 2018
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8
Recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +129 more
- Cyclophosphamide
- +3 more
-
Jacksonville, FloridaMayo Clinic in Florida
Apr 8, 2022
Lymphoma Trial in Baltimore (biological, drug, procedure)
Completed
- Lymphoma
- filgrastim
- +12 more
-
Baltimore, MarylandMarlene & Stewart Greenebaum Cancer Center, University of Maryla
Oct 31, 2019
Prostate Cancer Trial in San Francisco (sargramostim, ketoconazole, therapeutic hydrocortisone)
Completed
- Prostate Cancer
- sargramostim
- +2 more
-
San Francisco, California
- +1 more
Aug 1, 2019
Ganglioneuroblastoma, Neuroblastoma Trial in Canada, Puerto Rico, United States (procedure, drug, biological, radiation)
Recruiting
- Ganglioneuroblastoma
- Neuroblastoma
- Autologous Hematopoietic Stem Cell Transplantation
- +18 more
-
Birmingham, Alabama
- +158 more
Sep 14, 2022
Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer Trial in
Completed
- Recurrent Fallopian Tube Cancer
- +23 more
- ALVAC(2)-NY-ESO-1 (M)/TRICOM vaccine
- +3 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Mar 25, 2020
Pulmonary Alveolar Proteinosis, Autoimmune Trial in Niigata (Sargramostim, Placebo)
Completed
- Pulmonary Alveolar Proteinosis, Autoimmune
- Sargramostim
- Placebo
-
Niigata, JapanNiigata University Med & Dental Hospital
Feb 6, 2019